Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
WSK-V201
- Development stage
- Preclinical
- Lead developer
- WestVac Biopharma
- Modality
- Vaccines & Immunotherapeutics
01
Overview
WSK-V201 is an investigational, irradiated whole-cell inactivated bacterial vaccine being developed by WestVac Biopharma for the prevention and treatment of *Pseudomonas aeruginosa* infections. The vaccine is produced by obtaining *Pseudomonas aeruginosa* bacterial cells and subjecting them to radiation (such as gamma irradiation) to inactivate the pathogen while preserving its immunogenic surface antigens. This process is designed to induce protective humoral and cell-mediated immunity against multidrug-resistant *Pseudomonas aeruginosa*, thereby reducing bacterial load and preventing severe pulmonary infections, particularly in vulnerable populations such as patients with chronic obstructive pulmonary disease (COPD) or those in intensive care units. WSK-V201 is currently in preclinical development.
- Other names
- Novel Pseudomonas aeruginosa Vaccine
02
Targets
P. aeruginosa (Pseudomonas aeruginosa)
Beyond the preview
Go deeper on WSK-V201.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WSK-V201.